vs
Side-by-side financial comparison of AGENUS INC (AGEN) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $26.9M, roughly 1.3× WEST BANCORPORATION INC). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -31.0%, a 70.3% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs 16.6%). Over the past eight quarters, WEST BANCORPORATION INC's revenue compounded faster (17.3% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
AGEN vs WTBA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $26.9M |
| Net Profit | $-10.6M | $10.6M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | 50.0% |
| Net Margin | -31.0% | 39.2% |
| Revenue YoY | 27.5% | 16.6% |
| Net Profit YoY | 77.3% | 34.8% |
| EPS (diluted) | $0.09 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $34.2M | $24.2M | ||
| Q3 25 | $30.2M | $25.0M | ||
| Q2 25 | $25.7M | $23.8M | ||
| Q1 25 | $24.1M | $23.1M | ||
| Q4 24 | $26.8M | $20.9M | ||
| Q3 24 | $25.1M | $20.3M | ||
| Q2 24 | $23.5M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $-10.6M | $7.4M | ||
| Q3 25 | $63.9M | $9.3M | ||
| Q2 25 | $-30.0M | $8.0M | ||
| Q1 25 | $-26.4M | $7.8M | ||
| Q4 24 | $-46.8M | $7.1M | ||
| Q3 24 | $-67.2M | $6.0M | ||
| Q2 24 | $-54.8M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | 42.1% | 39.6% | ||
| Q3 25 | -15.0% | 45.8% | ||
| Q2 25 | -65.0% | 43.4% | ||
| Q1 25 | -55.3% | 43.4% | ||
| Q4 24 | -96.5% | 30.9% | ||
| Q3 24 | -125.5% | 36.6% | ||
| Q2 24 | -128.4% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | -31.0% | 30.7% | ||
| Q3 25 | 211.4% | 37.3% | ||
| Q2 25 | -116.8% | 33.5% | ||
| Q1 25 | -109.6% | 34.0% | ||
| Q4 24 | -174.4% | 34.0% | ||
| Q3 24 | -267.7% | 29.3% | ||
| Q2 24 | -233.1% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $0.09 | $0.44 | ||
| Q3 25 | $1.94 | $0.55 | ||
| Q2 25 | $-1.00 | $0.47 | ||
| Q1 25 | $-1.03 | $0.46 | ||
| Q4 24 | $-1.95 | $0.41 | ||
| Q3 24 | $-3.08 | $0.35 | ||
| Q2 24 | $-2.52 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $362.0M |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $270.7M |
| Total Assets | $226.8M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $3.0M | $471.1M | ||
| Q3 25 | $3.5M | $232.9M | ||
| Q2 25 | $9.5M | $345.2M | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $40.4M | $243.5M | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $93.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $-271.1M | $266.0M | ||
| Q3 25 | $-274.1M | $255.1M | ||
| Q2 25 | $-354.6M | $240.9M | ||
| Q1 25 | $-341.8M | $237.9M | ||
| Q4 24 | $-326.4M | $227.9M | ||
| Q3 24 | $-292.3M | $235.4M | ||
| Q2 24 | $-241.3M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $226.8M | $4.1B | ||
| Q3 25 | $233.9M | $4.0B | ||
| Q2 25 | $185.2M | $4.1B | ||
| Q1 25 | $200.2M | $4.0B | ||
| Q4 24 | $226.3M | $4.0B | ||
| Q3 24 | $238.5M | $4.0B | ||
| Q2 24 | $292.4M | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $12.9M |
| Free Cash FlowOCF − Capex | — | $12.4M |
| FCF MarginFCF / Revenue | — | 46.0% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-16.6M | $46.5M | ||
| Q3 25 | $-14.7M | $11.4M | ||
| Q2 25 | $-20.2M | $13.5M | ||
| Q1 25 | $-25.6M | $9.7M | ||
| Q4 24 | $-28.7M | $39.8M | ||
| Q3 24 | $-53.3M | $12.9M | ||
| Q2 24 | $-38.2M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | — | $43.2M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | $-20.2M | $12.8M | ||
| Q1 25 | $-25.6M | $8.3M | ||
| Q4 24 | $-28.7M | $13.7M | ||
| Q3 24 | $-53.3M | $7.0M | ||
| Q2 24 | $-38.6M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | -78.7% | 53.6% | ||
| Q1 25 | -106.5% | 35.7% | ||
| Q4 24 | -107.0% | 65.6% | ||
| Q3 24 | -212.2% | 34.2% | ||
| Q2 24 | -164.4% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 0.0% | 13.7% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.0% | 6.5% | ||
| Q4 24 | 0.3% | 125.3% | ||
| Q3 24 | 0.0% | 29.4% | ||
| Q2 24 | 2.0% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | -0.23× | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
WTBA
Segment breakdown not available.
